Business context and reporting period
The supplied filing is Schweitzer-Mauduit International, Inc.’s Form 10-K for the fiscal year ended December 31, 2016—not a filing under the Mativ Holdings, Inc. name. It reports two segments: Engineered Papers (EP), primarily tobacco-related papers and reconstituted tobacco, and Advanced Materials & Structures (AMS), specialty resin-based products. The company said non-tobacco sales had risen to about 40% of total sales in 2016.
Financial performance and position
- Revenue: $839.9 million, up 9.9% from $764.1 million. AMS sales increased 55.7% to $280.6 million, largely reflecting a full year of Argotec; EP sales fell 4.2% to $559.3 million.
- Profit and margins: Gross profit was $256.7 million, with a 30.6% gross margin versus 29.4%. Operating profit was $106.1 million, up 3.0%, but operating margin declined to 12.6% from 13.5%. Net income was $82.8 million, down from $89.7 million; diluted EPS was $2.70 versus $2.94.
- Segment operating profit: EP generated $138.0 million, up from $121.5 million. AMS generated $9.0 million, down from $16.7 million, including $21.3 million of restructuring and impairment expense.
- Cash flow: Operating cash flow was $129.7 million, down from $144.7 million. Management reported approximately $99 million of free cash flow, calculated as operating cash flow less $27.8 million of capital expenditures and $2.8 million of capitalized software costs.
- Debt and liquidity: Year-end debt was $440.4 million, down from $571.5 million, and cash was $107.4 million, down from $186.5 million. Revolver availability was $518.9 million; the company reported compliance with credit covenants. Debt to capital was 46.4%, versus 55.0%.
- Shareholder returns: Dividends paid were $49.4 million, or $1.62 per share, compared with $46.9 million, or $1.54 per share, in 2015.
Material changes versus the prior period
- Revenue growth was primarily acquisition-driven: Argotec contributed $106.5 million of incremental AMS sales. EP’s $24.6 million sales decline reflected unfavorable combined volume, mix and pricing, partly offset by currency effects.
- Interest expense rose to $16.6 million from $9.7 million, mainly due to higher average borrowings associated with Argotec and a higher effective borrowing rate.
- Restructuring and impairment expense rose to $25.6 million from $14.6 million, principally because of a $20.7 million impairment of the DelStar trade name following the decision to phase it out as part of a unified SWM brand.
- Operating cash flow declined, including an adverse year-over-year working-capital swing of $23.8 million. Cash balances also fell as the company repaid debt and funded dividends.
- In January 2017, after year-end, the company acquired Conwed for $295 million in cash, with up to $40 million in potential earn-outs. The purchase was funded primarily with credit-facility borrowings and is not included in 2016 operating results.
Outlook, risks and unusual items
- Management expected non-tobacco sales to reach roughly 50% of total sales in 2017 and anticipated a more balanced profit mix as AMS scales and integrates. It cited expected Conwed contributions and targeted annualized synergies of $10 million by the end of 2018; these are forecasts, not reported results.
- Expected 2017 offsets included lower French RTL volumes, reduced LIP royalties, higher taxes in certain jurisdictions and higher interest expense. Priorities included Conwed integration, AMS margin improvement, restructuring EP capacity to demand, and continued diversification.
- Key business risks include declining cigarette consumption and tobacco regulation; dependence on major tobacco customers; pricing and competition; raw-material and energy cost volatility; currency and interest-rate exposure; acquisition integration and synergy execution; and legal, tax, environmental and pension exposures.
- Brazilian tax assessments remain contested: a roughly $13 million raw-material tax assessment and electricity assessments of approximately $5 million, $9 million and $4 million. The company recorded no liability for these assessments and cautioned that outcomes are uncertain.
- Several European patent proceedings concern LIP technology, including revoked or appealed patents. The company also disclosed a $17.2 million carrying value for the Philippines RTL facility held for sale, which could be subject to further impairment.
- Fourth-quarter 2016 operating profit was $6.2 million and included $21.6 million of restructuring and impairment expense, principally the DelStar trade-name write-down. The filing describes unusual EP seasonality after European customer inventory builds reversed in the second half of 2016.
- The financial statements received an unqualified audit opinion; the auditor also reported effective internal control over financial reporting as of year-end.
Important facts for investors to verify
- Confirm the issuer and period: the source is SWM’s 2016 Form 10-K, despite the request metadata naming Mativ Holdings, Inc. and 2016 Q4.
- Track post-acquisition debt, covenant headroom and cash generation after the $295 million Conwed purchase, including whether projected synergies materialize.
- Assess whether AMS can improve margins despite its 2016 operating-profit decline and whether EP can manage secular tobacco declines and customer concentration.
- Monitor the disputed Brazilian assessments, LIP patent appeals and disposition or valuation of the Philippines facility.
- Reconcile management’s free-cash-flow measure and 2017 outlook against subsequent reported results; neither is a guarantee of future performance.